U.S. pharmaceutical company Eli Lilly plans to disclose the topline results of its phase 3 clinical trial for remternemab, a new drug candidate developed as a successor to its Alzheimer’s treatment ...

Under the terms of the collaboration, Iktos will apply its generative AI and AI-orchestrated robotics platform to design, ...

U.S. President Donald Trump has vañidated the concerns of many by stating that the U.S. could begin land strikes on drug ...

Additionally, Morgan Stanley reduced its price target for GoodRx from $5 to $4 while maintaining an Equal Weight rating on ...

SAN FRANCISCO -- Almost 80% of patients with heavily pretreated advanced/metastatic pancreatic cancer achieved disease ...

Enrollment milestone achieved ahead of schedule as Solaris DE drug-eluting continues to gather additional clinical ...

University Heights police responded to a call from a woman involved in an altercation while in a car and, after investigation ...

A new wave of dangerous drug cocktails is putting lives at risk as dealers mix xylazine and nitazenes with fentanyl ...

Dow Jones Top Company Headlines at 7 PM ET: Merck in Talks to Buy Revolution Medicines for Around $30 Billion | Meta ... Revolution is developing drugs that target a molecular driver of cancers. The ...

A Newsweek map shows the dominant Mexican drug cartel areas against which President Donald Trump has vowed a crackdown. Trump ...

Trump’s description of the Mexican trafficking world – one dominated by a few cartels that can be swiftly defeated – is at ...

A Greenwood Police Department unit is preparing to make the jump to full-time after a year of getting guns, drugs and wanted ...